Impact factor jama oncol
Witryna6 kwi 2024 · JAMA Oncology – Cancer Treatment, Genetics, & Prevention Explore the latest in cancer science including checkpoint inhibitors, DCIS, breast prostate and … WitrynaThis study aims to show that split-course therapy may achieve good local control tumor response rates at 6 months for those patients who are unfit to tolerate continuous therapy, and may be better tolerated, with decreased side effects. 103 Appropriate patient selection is critical, given that split-course therapy carries the potential risk of ...
Impact factor jama oncol
Did you know?
Witryna1 mar 2024 · JAMA Oncol. 2024 Mar 1;7(3):386 ... Although treatment with first-generation epidermal growth factor receptor (EGFR) ... (80 mg, every day) plus intravenous bevacizumab (15 mg/kg, every 3 weeks) until progression or unacceptable toxic effects. The control arm received osimertinib monotherapy. Witryna2024 Journal Metrics. On this page you will find a suite of citation-based metrics for Nature Reviews Clinical Oncology which provides an overview of this journal. Because the median is not ...
Witryna1 lip 2024 · The impact factor is calculated by dividing the number of times the articles are cited in the last two years by the total number of publications in those two years. … Witryna11 lis 2024 · This cohort study compares the toxic effects and oncologic outcomes associated with intensity-modulated radiation therapy (IMRT) vs intensity-modulated proton t ... JAMA Oncol. 2024;8(3):364-372. doi: ... IMPT was the only factor associated with significantly lower likelihood of developing grade 3 or greater acute …
Witryna1 gru 2024 · In the largest evaluation of fatal ICI-associated toxic effects published to date to our knowledge, we observed early onset of death with varied causes and … Witryna12 kwi 2024 · Lymph node status is an important long-term prognostic factor for patients with iCCA. 32 Specifically, the presence of lymph node metastases not only adversely affects OS but also influences the relative effect of tumor number and vascular invasion on survival. 33 Therefore, assessment of the nodal basin should be performed at …
WitrynaJCO is one of the most prestigious oncology journals in the world, with an Impact Factor of 50.717, placing it among the top 1% of all journals, and with an Eigenfactor of 0.24903, which is the highest among oncology publications. In addition, JCO has the highest h-index among oncology journals reported by Google Scholar Metrics.
WitrynaJAMA Oncol. 2024 Aug 15;5(11):1605-1613. doi: 10.1001/jamaoncol.2024.2109. Online ahead of print. ... Importance: To our knowledge, no randomized clinical trials have assessed the effects of the combination of weight loss and home-based exercise programs on lymphedema outcomes. shanly foundation south eastWitryna2374-2437 (print) 2374-2445 (web) Links. Journal homepage. Online access. Online archive. JAMA Oncology is a monthly peer-reviewed medical journal published by the American Medical Association. It covers all aspects of medical oncology, radiation oncology, and surgical oncology, as well as subspecialties. The journal was … polynesian tribal tattoos for womenWitrynaThe journal’s impact factor of 31.8 placed us as one of the highest-ranking oncology journals. Choosing the best articles for the journal was rewarding but challenging. We … shanly homes mill road epsomWitrynaThe Journal Impact Factor is defined as all citations to the journal in the current JCR year to items published in the previous two years, divided by the total number of … polynesian tattoo artist californiaWitrynaJAMA Oncology is committed to publishing influential original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer. ... three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric. Cites per ... polynesian tribal tattoo meanings symbolsWitrynaThe Lancet Oncology is an internationally trusted source of clinical, public health, and global health knowledge. With an Impact Factor of 54·433, we are the world-leading clinical oncology research journal globally (2024 Journal Citation Reports ®, Clarivate 2024). We recognise that the Journal Impact Factor is just one measure of a journal ... polynesian villas and bungalows reviewsWitryna5 lip 2024 · Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. ... JAMA Oncol. 2024;5(10):e191870. doi: ... Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: findings from an American Society of Clinical Oncology Survey. shanly homes the gables